Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology. Issue 1 (31st August 2015)

• Record Type: Journal Article
• Authors: Zhang, Zhouwei; Weaver, Donald L; Olsen, Daniel; deKay, James; Peng, Zhihua; Ashikaga, Takamaru; Evans, Mark F
• Is Part Of: Journal of clinical pathology. Volume 69:Issue 1(2016)
• Page Start: 76
• Page End: 81
• Publication Date: 2015-08-31
• Subjects: BREAST CANCER -- IN SITU HYBRIDISATION -- TUMOUR MARKERS; Pathology -- Periodicals; Pathology, Molecular -- Periodicals; 616.0705
• DOI: 10.1136/jclinpath-2015-203275
• Languages: English
• ISSNs: 0021-9746

Abstract

Abstract : Aim: Long non-coding RNAs (lncRNAs) are potential biomarkers for breast cancer risk stratification. LncRNA expression has been investigated primarily by RNA sequencing, quantitative reverse transcription PCR or microarray techniques. In this study, six breast cancer-implicated lncRNAs were investigated by chromogenic in situ hybridisation (CISH). Methods: Invasive breast carcinoma (IBC), ductal carcinoma in situ (DCIS) and normal adjacent (NA) breast tissues from 52 patients were screened by CISH. Staining was graded by modified Allred scoring. Results: HOTAIR, H19 and KCNQ1OT1 had significantly higher expression levels in IBC and DCIS than NA (p<0.05), and HOTAIR and H19 were expressed more strongly in IBC than in DCIS tissues (p<0.05). HOTAIR and KCNQ101T were expressed in tumour cells; H19 and MEG3 were expressed in stromal microenvironment cells; MALAT1 was expressed in all cells strongly and ZFAS1 was negative or weakly expressed in all specimens. Conclusion: These data corroborate the involvement of three lncRNAs ( HOTAIR, H19 and KCNQ1OT1 ) in breast tumourigenesis and support lncRNA CISH as a potential clinical assay. Importantly, CISH allows identification of the tissue compartment expressing lncRNA.